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PTP1B Regulates Leptin Signal Transduction In Vivo
obesity and its complications in rodents and humansJanice M. Zabolotny,1,6 Kendra K. Bence-Hanulec,2,6
(Ahima and Flier, 2000). Therefore, understanding theAlain Stricker-Krongrad,4 Fawaz Haj,2
regulation of LepR signaling is of substantial biomedicalYongping Wang,2 Yasuhiko Minokoshi,1
importance.Young-Bum Kim,1 Joel K. Elmquist,1,3
LepR is a type I cytokine receptor that associates withLouis A. Tartaglia,4 Barbara B. Kahn,1,5,6
the protein-tyrosine kinase Jak2 (Ahima and Flier, 2000;and Benjamin G. Neel2,6
Tartaglia, 1997). Upon leptin binding, Jak2 becomes ac-1Division of Endocrinology and Metabolism and
tivated and phosphorylates itself and LepR, which then2 Cancer Biology Program
recruits signal relay molecules, such as Stat3 (AhimaDivision of Hematology and Oncology
and Flier, 2000; Tartaglia, 1997). Tyrosyl phosphorylatedDepartment of Medicine
Stat3 dimerizes, translocates to the nucleus, and regu-3 Department of Neurology and Program
lates the transcription of target genes, including thosein Neuroscience
encoding orexigenic and anorexigenic neuropeptidesBeth Israel Deaconess Medical Center and
(Ahima and Flier, 2000; Spiegelman and Flier, 2001).Harvard Medical School
Activated LepR also stimulates the Erk MAP kinaseBoston, Massachusetts 02215
pathway (Banks et al., 2000; Bjorbaek et al., 2001) and4 Millennium Pharmaceuticals
regulates ion channels (Cowley et al., 2001; SpanswickCambridge, Massachusetts 02138
et al., 1997).
Little is known about how LepR signaling is termi-
nated. Initial studies of LepR mutants suggested a nega-Summary
tive regulatory role for the protein-tyrosine phosphatase
Shp2 (Carpenter et al., 1998; Li and Friedman, 1999).Mice lacking the protein-tyrosine phosphatase PTP1B
However, Socs-3, which binds to the same site on LepRare hypersensitive to insulin and resistant to obesity.
as Shp2, may actually mediate this inhibitory signalHowever, the molecular basis for resistance to obesity
(Bjorbaek et al., 2000). Negative regulation by Socs-3has been unclear. Here we show that PTP1B regulates
involves LepR-evoked transcription and new proteinleptin signaling. In transfection studies, PTP1B de-
synthesis (Bjorbaek et al., 2000; Krebs and Hilton, 2000).phosphorylates the leptin receptor-associated kinase,
Whether (and how) acute regulation of LepR signalingJak2. PTP1B is expressed in hypothalamic regions
occurs has remained unclear.harboring leptin-responsive neurons. Compared to
Recently, PTP1B/ mice were generated (Elchebly etwild-type littermates, PTP1B/ mice have decreased
al., 1999; Klaman et al., 2000). Consistent with earlierleptin/body fat ratios, leptin hypersensitivity, and en-
suggestions that PTP1B regulates insulin receptor (IR)hanced leptin-induced hypothalamic Stat3 tyrosyl
signaling (Goldstein et al., 1998), these mice are hyper-phosphorylation. Gold thioglucose treatment, which
sensitive to insulin and exhibit enhanced and/or pro-ablates leptin-responsive hypothalamic neurons, par-
longed IR tyrosyl phosphorylation in liver and muscletially overcomes resistance to obesity in PTP1B/
(Elchebly et al., 1999; Klaman et al., 2000). Togethermice. Our data indicate that PTP1B regulates leptin
with structural and kinetic studies (Salmeen et al., 2000),signaling in vivo, likely by targeting Jak2. PTP1B may
these findings establish PTP1B as a physiological IRbe a novel target to treat leptin resistance in obesity.
phosphatase. PTP1B/ mice also display resistance to
high-fat diet-induced obesity (Elchebly et al., 1999; Kla-
Introduction man et al., 2000). This is due, at least in part, to increased
energy expenditure in PTP1B/ mice, although their
Regulation of body mass is essential for mammalian food intake may also not be increased appropriately for
survival (Spiegelman and Flier, 2001), and disorders of their lowered body fat (Klaman et al., 2000). How PTP1B
body mass control (e.g., obesity) contribute to the patho- regulates body mass is unknown.
genesis of many important human diseases, including
type II diabetes (Kopelman, 2000). The adipocyte- Results
derived hormone leptin plays a key role in body mass
regulation (Ahima and Flier, 2000). Although leptin af- PTP1B Regulates Leptin Signaling In Vitro
fects multiple tissues, in normal rodents (and probably A recent study suggested that PTP1B might dephos-
normal humans), many of its effects on body mass are phorylate Stat5 (Aoki and Matsuda, 2000), whereas
mediated by neurons in the mediobasal hypothalamus structural and kinetic analyses indicated that Janus ki-
(Dawson et al., 1997; Elmquist et al., 1999; Fei et al., nases (e.g., Jak2) should be favorable PTP1B substrates
1997). Leptin binding to receptors on these neurons (Salmeen et al., 2000). To test the hypothesis that PTP1B
suppresses food intake and increases energy expendi- might regulate LepR signaling, we first carried out tran-
ture (Ahima and Flier, 2000). Naturally occurring muta- sient transfection studies. Transfection of a LepR
tions of leptin or the leptin receptor (LepR) cause morbid expression construct into Cos-7 cells conferred leptin-
evoked tyrosyl phosphorylation of Jak2 and Stat3 (Fig-
ure 1), as reported (Bjorbaek et al., 1997; Carpenter et al.,5 Correspondence: bkahn@caregroup.harvard.edu
6 These authors contributed equally to this work. 1998; Li and Friedman, 1999). Coexpression of PTP1B
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Figure 1. PTP1B Regulates Leptin Signaling
(A) PTP1B regulates LepR signaling in Cos-7 cells. Upper panel: Cos-7 cells transfected with expression constructs for LepR alone (left two
lanes) or together with PTP1B (right two lanes) were stimulated with leptin or left unstimulated. Anti-PTP1B and anti-pStat3 immunoblots of
total lysates and anti-pTyr immunoblots of anti-Jak2 immunoprecipitates are shown. Lower panel: Cos-7 cells transfected with a LepR
expression construct and increasing amounts of PTP1B expression vector were stimulated with leptin. Lysates resolved by SDS-PAGE were
immunoblotted with anti-PTP1B, anti-phospho-Jak2 (Y1007/Y1008), anti-Jak2, anti-phospho-Stat3, or anti-Stat3 antibodies.
(B) PTP1B regulates Jak2 phosphorylation in PTP1B/ fibroblasts. Lysates from LepR-expressing PTP1B/ fibroblasts or LepR-expressing
PTP1B/ fibroblasts reconstituted with PTP1B were stimulated with leptin () or left unstimulated (), and immunoblotted with anti-pStat3
(upper panel), anti-pJak2 (lower left panel), or anti-phosphotyrosine (lower right panel). In some experiments, there was a further increase in
Jak2 and Stat3 tyrosyl phosphorylation following leptin stimulation, but this was not observed consistently.
(C) Upper panel: 293 cells transiently expressing LepR were stimulated with leptin, and incubated with GST-PTP1BC215S or GST. Bound
proteins were resolved by SDS-PAGE and immunoblotted with anti-pTyr or anti-Jak2 antibodies, as indicated. The 180 kDa pY species bound
to the GST-PTP1BC215S is probably the EGFR (see Flint et al., 1997). Lower panel: PTP1B/ fibroblasts expressing PTP1BD181A were
stimulated with leptin, lysed in the absence (left four lanes) or presence (right four lanes) of sodium orthovanadate, immunoprecipitated with
anti-PTP1B, and immunoblotted with anti-Jak2.
(D and E) Enhanced Stat3 activation in PTP1B/ hypothalami. Hypothalamic extracts from male mice injected with saline () or leptin ()
were resolved by SDS-PAGE and immunoblotted with anti-pStat3 antibodies. A representative immunoblot of 4-month-old mice is shown (D);
similar data were obtained in 8- to 10-week-old mice. Results from multiple experiments were quantified by densitometry and expressed as
percent of the WT value (E). WT (n  19), PTP1B/ (n  18) mice. *p  0.006.
suppressed leptin-induced Jak2 and Stat3 phosphoryla- and either an empty expression vector, or wild-type (WT)
or mutant forms of PTP1B. PTP1B/ cells reconstitutedtion (Figure 1A, left panel) and induction of a Stat-
dependent transcriptional reporter (data not shown). Im- with WT PTP1B showed little or no phospho-Stat3 reac-
tivity either basally (i.e., serum-starved) or in responsemunoblots with phospho-specific antibodies confirmed
that PTP1B suppresses phosphorylation of the Jak2 ac- to leptin stimulation. In contrast, Jak2 and Stat3 tyro-
sine phosphorylation were detectable constitutively intivation site tyrosines (Y1007/Y1008) and Stat3 in a
dose-dependent manner (Figure 1A, lower panel). These PTP1B/ cells (Figure 1B, upper and lower left panels).
Constitutive Jak2 and Stat3 phosphorylation in thesetwo Jak2 phosphotyrosines are those predicted to be
preferred PTP1B targets (Salmeen et al., 2000). Our re- cells also is consistent with PTP1B regulation of Jak2
phosphorylation. Notably, total cellular tyrosine phos-sults suggest that PTP1B acts on Jak2, although addi-
tional actions on Stat3 or LepR are not excluded. Similar phorylation in fibroblasts lacking PTP1B was similar to
WT (Figure 1B, lower right panel), arguing against aresults were obtained using 293 cells (data not shown).
We also analyzed fibroblast lines derived from global perturbation of tyrosine kinase pathways in the
absence of PTP1B.PTP1B/ mice and engineered to stably express LepR
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Figure 2. In Situ Hybridization
(A and B) PTP1B (A) and LepR (B) antisense
riboprobes hybridized to rat brain.
(C) PTP1B antisense riboprobe hybridized to
WT mouse brain. Note in (A) and (C) the strong
hybridization to CA3 of the hippocampus, as
well as hybridization elsewhere, including the
arcuate (Arc), ventromedial hypothalamic
(VMH), and dorsomedial hypothalamic (DMH)
nuclei.
(D) PTP1B antisense probe hybridized to
PTP1B/ mouse brain.
Jak2 Is a Substrate of PTP1B DC1). Thus, PTP1B is expressed within hypothalamic
regions in which LepR functions to regulate body mass.Further evidence was provided by experiments with two
PTP1B “substrate-trapping” mutants, C215S and
D181A, which have markedly diminished catalytic activ- PTP1B/ Mice Are Hypersensitive to Leptin
Comparisons of body fat and leptin levels in PTP1B/ity but retain substrate binding ability (Flint et al., 1997).
A GST-PTP1BC215S fusion protein bound Jak2 from and WT mice raised the possibility that PTP1B/ mice
might be hypersensitive to leptin. On high-fat diets,leptin-stimulated 293 cells transiently expressing LepR
(Figure 1C, upper panel). Likewise, Jak2 coimmunopre- PTP1B/ mice gain much less weight than WT (Elchebly
et al., 1999; Klaman et al., 2000) and have markedlycipitated with PTP1BD181A reexpressed in PTP1B/
fibroblasts. Importantly, this interaction was reduced diminished body fat (Klaman et al., 2000). On a low-fat
(4.5% by weight) diet, PTP1B/ and WT mice gainmarkedly in the presence of the competitive inhibitor
sodium orthovanadate (Figure 1C, lower panel). We did weight at similar rates (Elchebly et al., 1999 and data
not shown). However, even under these conditions,not detect association of Stat3 with PTP1B in the same
immunoprecipitation (not shown). Thus, D181A/Jak2 in- PTP1B/ mice had decreased fat pad mass and total
carcass lipid (Table 1). Normally, serum leptin levels areteraction occurs via the active site of PTP1B, consistent
with Jak2 being a PTP1B substrate in vivo. Furthermore, proportional to body fat mass (Ahima and Flier, 2000)
and, consistent with their decreased fat mass, PTP1B/transient coexpression of the D181A mutant and LepR
in 293 cells resulted in enhanced leptin-evoked Jak2 mice had lower leptin levels. However, the leptin/body
fat ratio also was significantly decreased in PTP1B/tyrosine phosphorylation (data not shown).
mice on low- (Table 1) and high-fat (data not shown;
see Klaman et al., 2000) diets. This suggests increasedPTP1B Is Expressed in Hypothalamus
We next asked whether PTP1B is expressed in regions leptin sensitivity, since PTP1B/ mice maintain their
leanness at lower leptin levels than WT.of the brain important for body mass control. In situ
hybridizations to both rat and WT mouse brains revealed To directly assess leptin sensitivity, we compared the
response of WT, PTP1B/, and PTP1B/mice to exoge-significant hybridization in the hippocampus, as re-
ported (Guan and Dixon, 1990), and throughout the brain nous leptin. Body fat levels influence leptin sensitivity
(Ahima and Flier, 2000). Therefore, for these studies,including the hypothalamus, where hybridization was
detected in the arcuate, ventromedial hypothalamic, and we used lean mice with similar levels of body fat as
measured by dual energy X-ray absorptiometry (see Fig-dorsomedial hypothalamic nuclei (Figures 2A and 2C).
Notably, the pattern of PTP1B expression in the hypo- ure 3 legend). Mice (male, 6–8 per group) from each
genotype were injected intraperitoneally (i.p.) with phos-thalamus was similar to that of LepR (Figure 2B). No
signal was observed using the antisense probe and phate-buffered saline (PBS) vehicle or leptin (1–20 mg/
kg/day in two divided doses; Figures 3A and 3B). In WTbrains from PTP1B/ mice (Figure 2D) or the corre-
sponding sense probe and WT brains (data not shown). mice, only the highest leptin dose caused significant
declines in body mass and food intake (left panels). InImmunoblots confirmed widespread expression of
PTP1B protein in murine brain including the hypotha- contrast, PTP1B/ mice responded to all doses of leptin
tested (right panels), whereas PTP1B/ mice exhibitedlamus (see Supplemental Figure S1 at http://www.
developmentalcell.com/cgi/content/full/2/4/489/ intermediate leptin sensitivity (middle panels). Thus, in a
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Table 1. Body Composition Analysis
BW Carcass Lipid Perigonadal Fat Pad Leptin Leptin/Fat Pad
Genotype (g) (g) (mg) (ng/ml) (ng/ml-mg1)
Wild-type 25.79  0.74 8.84  0.55 375.7  29.8 4.20  0.73 10.74  1.07
(12) (6) (12) (6) (6)
PTP1B/ 25.21  0.56 5.62  0.73* 237.1  22.9* 2.17  0.28* 8.56  0.60*
(12) (5) (12) (7) (7)
Body weight (BW), carcass lipid, perigonadal fat pad weight, and fed leptin levels of 8- to 11-week-old male mice fed a 4.5% (by weight) fat
diet are shown. Number of animals is indicated in parentheses. Data are expressed as means SEM. *p  0.05 by Student’s t test.
gene dosage-dependent manner, PTP1B regulates total studies (Figure 1) and the structural/kinetic studies of
Salmeen et al. (2000), we believe PTP1B action is mostbody leptin sensitivity of pathways regulating body
mass. likely at the level of Jak2. Importantly, LepR mRNA lev-
els, measured by real-time PCR, were the same in WTIncreased leptin sensitivity correlated with enhanced
hypothalamic LepR signaling. Following peripheral lep- and PTP1B/ mice (data not shown). Thus, our results
suggest that PTP1B acutely regulates hypothalamictin injection, Stat3 activation was35% higher (p0.01)
in the hypothalami of PTP1B/ mice (n 18, 135.8 7.3 LepR signaling.
arbitrary units) compared with WT (n  19, 100  8.2),
as determined by densitometry of immunoblots from Intact Hypothalamic Function Is Necessary but
Not Sufficient for Leanness of PTP1B/ Micefour separate experiments (Figures 1D and 1E). We were
unable to detect LepR or Jak2 tyrosyl phosphorylation Loss of PTP1B regulation of LepR signaling could con-
tribute to the decreased fat mass and resistance to obe-or Erk activation in hypothalami from leptin-stimulated
WT or PTP1B/ mice (data not shown), most likely re- sity of PTP1B/ mice. To assess whether altered hypo-
thalamic signaling contributes to the PTP1B/ bodyflecting inadequate sensitivity of available reagents. En-
hanced Stat3 tyrosyl phosphorylation in PTP1B/ hypo- mass phenotype, we administered gold thioglucose
(GTG) to WT and PTP1B/ mice. GTG destroys LepR-thalami could reflect action of PTP1B on Stat3 or on an
upstream component(s) of the LepR pathway, such as expressing neurons in the mediobasal hypothalamus
(Bergen et al., 1998; Elmquist et al., 1998; Fei et al.,Jak2 and/or LepR. Based on our transient transfection
Figure 3. PTP1B/ Mice Are Hypersensitive to Leptin
(A) Food intake in leptin-treated wild-type (WT), PTP1B/ (Hets), and PTP1B/ (KO) mice. Since there is a large variation in fat content in
outbred mice, we were able to select 8- to 11-week-old mice that were matched for similar body fat content as measured by dual energy
X-ray absorptiometry. Male animals (6–8/group) were injected with vehicle (PBS) (open triangle) or 1 (filled triangles), 10 (open circles), or 20
(filled circles) mg/kg/day leptin i.p. (in two divided doses) during the 3 consecutive days indicated. Values represent mean daily food intake
(in grams) SEM.
(B) Effect of leptin on body weight. Shown are body weights expressed as % of weights at day 0 of mice in (A). Similar results were obtained
with female mice (data not shown). *p  0.05.
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1997) and causes hyperphagia and obesity (Debons et
al., 1977). If hypothalamic leptin hypersensitivity is an
important cause of the resistance to obesity in PTP1B/
mice, then PTP1B/ and WT mice should respond simi-
larly to GTG treatment. As expected, GTG injection
markedly disrupted the normal architecture of the me-
diobasal hypothalami, including the arcuate nuclei, of
both WT and PTP1B/ mice (Supplemental Figure S2).
GTG-treated WT and PTP1B/ mice exhibited signifi-
cantly and comparably increased food intake, indicating
that hypothalamic neurons had been ablated to similar
extents (Figure 4A). Compared to untreated controls,
GTG-treated WT and PTP1B/ mice also exhibited in-
creased body mass. However, the increase in body
mass of GTG-treated PTP1B/ mice was only about half
that of GTG-treated WT mice, despite their comparably
increased food intake (Figure 4B). These data further
support our previous finding that PTP1B/ mice have
enhanced energy expenditure (Klaman et al., 2000).
Moreover, as GTG-treated PTP1B/ mice are no longer
fully resistant to obesity, intact hypothalamic signaling,
most likely initiated by leptin-responsive neurons in
GTG-sensitive areas, appears to be required for the full
manifestation of the PTP1B/ body mass phenotype.
Importantly, however, since GTG-treated PTP1B/ mice
gain less weight than WT despite comparable food in-
take and brain lesions, PTP1B also must regulate body
mass pathways distal to those ablated by GTG, either
in the brain or the periphery.
Glucose homeostasis also differed in GTG-treated WT
and PTP1B/ mice. Blood glucose (at noon) was signifi-
cantly lower in GTG-treated PTP1B/ mice (135  6.7
mg/dl versus 164  6.8 mg/dl; p  0.05). Insulin toler-
ance tests (ITTs; Figure 4C) confirmed that GTG-treated
WT mice became more insulin resistant than untreated
controls. In contrast, GTG-treated PTP1B/ mice re-
mained as insulin sensitive as control untreated WT mice
(again, in spite of the increased body mass of PTP1B/
mice). Likewise, serum insulin levels were elevated in
GTG-treated WT mice, but not in GTG-treated PTP1B/
mice (Figure 4D). Thus, the two most striking phenotypes
caused by PTP1B deficiency, insulin hypersensitivity
and resistance to diet-induced obesity, appear to in-
volve different signaling pathways and/or sites of action.
Discussion
Our results, together with previous studies (Elchebly et
al., 1999; Klaman et al., 2000), indicate that PTP1B is a
key regulator of at least two critical metabolic pathways.
In muscle and liver (and possibly other tissues), PTP1B
negatively regulates insulin signaling by directly de-
phosphorylating the IR (Elchebly et al., 1999). Loss of
this regulation in PTP1B/ mice results in increased
insulin sensitivity (Elchebly et al., 1999; Klaman et al.,
Figure 4. Effect of GTG on WT and PTP1B/ (KO) Mice
2000). The results herein suggest that PTP1B also is a
WT (n  11) and PTP1B/ (n  13) male mice were treated with
GTG (0.4 mg/g body weight) at 5 weeks of age. Untreated WT mice
(n  5–12) served as controls. Data are means SEM.
(A) Food intake of WT  GTG and KO  GTG groups is increased
significantly compared to untreated WT mice by 1 week post-GTG from 2 to 7 weeks posttreatment.
treatment (p  0.05). (C and D) Insulin tolerance tests (C) and fed serum insulin levels (D)
(B) Weight gains expressed as % of weight at week 0 of WT GTG, were measured at 7 weeks post-GTG treatment. *WT  GTG is
KO  GTG, and WT are statistically different (p  0.05) at all points different from WT control and from KO  GTG; p  0.05.
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sodium orthovanadate (Harlow and Lane, 1988). In other experi-physiologically significant negative regulator of hypo-
ments, cells were lysed in RIPA buffer (Harlow and Lane, 1988).thalamic LepR signaling, where it most likely acts on
Immunoprecipitations (typically from 500 g clarified lysate) andJak2. Resistance of PTP1B/ mice to high-fat diet-
immunoblotting were carried out as described (Klaman et al., 2000)
induced obesity may be explained, in part, by loss of with anti-phosphotyrosine (PY99; Santa Cruz Biotechnology), anti-
this regulatory function. PTP1B (FG6; Oncogene Sciences), anti-pStat3 and polyclonal anti-
Jak2 (for immunoblotting; Upstate Biotechnology), anti-Jak2 (forPTP1B deficiency only partially “rescues” the effects
immunoprecipitation; Dwayne Barber, Ontario Cancer Institute),of GTG ablation on body mass, so leptin hypersensitivity
anti-pJak2 (Y1007/1008; Biosource), and anti-leptin receptor (Martinin GTG-sensitive neurons accounts for only part of the
Myers, Joslin Diabetes Center) antibodies.PTP1B/ body mass phenotype. Therefore, PTP1B
must have important targets in tissues distal to those
Miceablated by GTG. These could include leptin-responsive
WT, PTP1B/, and PTP1B/ mice (Klaman et al., 2000) were housed
neurons elsewhere in the brain (Elias et al., 2000; Elm- at 22C with a 12 hr light/dark cycle and fed a low-fat (4.5% by
quist et al., 1998) or leptin-responsive cells in the periph- weight) diet (Purina Autoclavable Rodent Diet 5010) ad libitum.
ery, such as muscle, fat, and liver (Ahima and Flier, 2000;
Minokoshi et al., 2002). PTP1B also may regulate central In Situ Hybridizations
IR signaling, and loss of this regulation could contribute Serial sections (30 m) from brains of 5- to 8-week-old mice or adult
rats perfused with 10% neutral buffered formalin were subjected toto resistance to obesity in PTP1B/ mice. Although the
in situ hybridization as described previously (Elias et al., 2000) usingrole of IR signaling in the brain remains unclear, the
35S-labeled sense and antisense riboprobes corresponding to nucle-phenotypes of brain-specific IR/ (Bruning et al., 2000)
otides 614–964 of murine PTP1B cDNA (GenBank accession number
and IRS-1/ (Burks et al., 2000) mice and data with GI 1292901).
insulinomimetic small molecule treatment (Air et al.,
2002) are consistent with insulin action in the brain regu-
Leptin Signaling in PTP1B/ Mice
lating body mass. Alternatively, PTP1B may regulate Murine leptin (Eli Lilly) was administered i.p. (1.67 g/g body weight)
another pathway(s) besides the IR and LepR that con- to mice fasted for 15–18 hr. Mice were sacrificed 45 min later and
the hypothalamus was rapidly dissected and frozen in liquid N2. Thetrols body mass; candidates include other cytokine re-
same fraction of hypothalamic lysate (in RIPA buffer) from eachceptors that signal via Jak2. Tissue-specific PTP1B de-
mouse was subjected to SDS-PAGE and anti-pStat3 immuno-letion should help to clarify these issues. It will also be
blotting.important to determine why PTP1B appears to regulate
Jak2 in some cell types (e.g., hypothalamic neurons),
Gold Thioglucose Treatmentwhereas other PTPs are required for Jak2 regulation in
Male mice (5 weeks old) were injected i.p. (0.4 mg/g body weight)
other cells (Irie-Sasaki et al., 2001; You et al., 1999), with aurothioglucose (Solganal; Schering). Twenty-four hr food in-
even though PTP1B is expressed ubiquitously. take and body weights were measured weekly. Lesions were con-
Our studies, along with those of Cheng et al. in this firmed by histological analysis. Mice were perfused with 10% neutral
buffered formalin, brains were cut at 30m on a freezing microtome,issue of Developmental Cell, indicate that PTP1B defi-
mounted on Superfrost Plus slides (Fischer), and stained with thi-ciency can attenuate weight gain in mice lacking normal
onine.hypothalamic leptin signaling. Since nearly all forms of
human obesity involve leptin resistance (Spiegelman
Metabolic Measurementsand Flier, 2001), these findings, along with the appar-
Blood glucose was measured using a One Touch II glucometer
ently benign effects of PTP1B deficiency in the mouse, (Lifescan). ITTs were performed as described (Klaman et al., 2000)
support the identification of PTP1B as a potential target on mice fasted for 5 hr using 0.5 mU/g body weight of insulin (Novolin
for prevention and therapy of obesity. R, Novo Nordisk). Serum insulin and leptin and body composition
analysis of carcass hydrolysates was carried out as described (Kla-
Experimental Procedures man et al., 2000).
Cells and Transfections Statistical Analyses
293 and Cos-7 cells were maintained in DMEM plus 10% FCS and Data are presented as means SEM. Statistical analyses were per-
antibiotics. Transfections were performed with Superfect using ex- formed using StatView or SuperANOVA software (Abacus Con-
pression constructs for LepR (under CMV control) and PTP1B (under cepts). Statistical significance was tested with unpaired Student’s
SV40 promoter/enhancer control). Details are available from t tests or factorial analysis of variance followed by Newman-Keuls
K.K.B.-H. upon request. Twenty-four to 36 hr posttransfection, cells multiple range test. Differences were considered significant if p 
were placed in serum-free DMEM for 14 hr, prior to stimulation with 0.05.
leptin (20–50 nM). The PTP1B/ fibroblast cell line was generated
by immortalizing primary embryo fibroblasts from PTP1B/ mice
Acknowledgmentswith large T antigen. PTP1B/ cells were infected with retroviruses
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